Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) emerged as a promising class of drugs and have been shown to be effective as a key regulator in managing glucose metabolism-associated diseases such as type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), cardiovascular effects, nephrological complications, diabetes, non-alcoholic fatty liver (NAFLD), as well as to control obesity
These codes apply when the counseling focuses on risk factor reduction and health behavior change rather than management of a specific illness
Like any medical treatment, lipotropic injections carry potential risks, and they are not appropriate for everyone
Step Therapy and Formulary Tiers Several BCBS affiliates impose step therapy for Zepbound
These actions enhance nutrient and oxygen delivery to aging tissues, encouraging collagen renewal and improved elasticity